- CHOCHOLATE Reduces Stroke Risk
- SIBUTRAMINE withdrawn from Market
- HIV Prevention with TRUVADA
- First Oral Drug for Multiple Sclerosis
SIBUTRAMINE withdrawn from Market
pulled the obesity drug sibutramine from the market in October in light of clinical trial data pointing to an increased risk for stroke and myocardial infarction. Roughly 100,000 people in the United States were taking sibutramine at the time.
HIV Prevention with TRUVADA
significant effectiveness against HIV infection in a major, multicontinent clinical trial. The HIV infection rate was 44% lower for those in the PrEP treatment group than for those in the placebo group. For individuals who took their pills on 90% or more of the days in the study, the risk for infection decreased by more than 70%. Experts called the trial results "game-changing" and said it was "a landmark study."